自主神经系统 (ANS) 活动的催眠调制.
1Department of Neurosurgery, University of Milano, 20125 Milano, Italy.
Brain sciences
|March 28, 2024
概括
催眠有效调节自主神经系统 (ANS),影响心率和呼吸等生理反应. 这种调制,特别是在放松期间,显示出治疗与ANS功能障碍相关的精神疾病的潜力.
科学领域:
- 心理生理学 心理生理学
- 神经科学是一个神经科学.
- 综合医学是一个整体的医学.
背景情况:
- 催眠是一种被公认的治疗心理和体质障碍的疗法.
- 虽然是中央调解的,但催眠也会影响周围自主神经系统 (ANS).
- 自主神经系统活动可以通过心理生理学指标测量,例如心率变化和电皮活动.
研究的目的:
- 审查催眠对自主神经系统 (ANS) 活动的影响.
- 通过催眠来探索中枢神经系统 (CNS) 和外围ANS调节之间的联系.
- 评估催眠诱导的ANS调制对于精神疾病的治疗潜力.
主要方法:
- 审查研究测量在催眠干预期间心理生理学参数的研究.
- 分析心率 (HR),心率变化 (HRV),皮电活动 (EDA),呼吸率 (RR) 和止痛感知指数 (ANI).
- 考虑影响ANS催眠效应的因素,包括催眠能力和任务条件.
主要成果:
- 催眠显著影响ANS功能,减少了交感活动,增加了副交感音调.
- 这些效应在放松方案期间更加明显.
- 催眠能力和特定任务条件介导ANS调节的程度.
结论:
- 催眠表现出通过中央和外围机制调节自主神经系统 (ANS) 的能力.
- 通过催眠增强的ANS调节,与中枢神经系统活动相关,可以优化对精神病状况的治疗.
- 尽管存在现有的方法限制,但需要进一步的研究,以充分利用与ANS相关疾病的催眠.
相关概念视频
Sedatives and Hypnotics: Overview
358
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
358
Autonomic Nervous System
8.8K
The autonomic nervous system (ANS) is a critical component of the peripheral nervous system, primarily responsible for regulating involuntary bodily functions and maintaining homeostasis. It functions in tandem with the central nervous system (CNS) to seamlessly coordinate various physiological processes without the need for conscious control.
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
8.8K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
171
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
171
The Parasympathetic Nervous System
107.0K
Overview
107.0K
Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
Drugs Acting on Autonomic Ganglia: Blockers
1.0K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.0K


